Moderna is trading 5% up now at $161.72, as U.S. equities open higher.
- The S&P 500 is up 0.65%, while the Nasdaq Composite is up 0.90%.
- The move appears aligned with broader risk-on positioning, supported by easing oil prices, lower bond yields, and stronger technology-sector sentiment.
- Moderna’s September 18 European patent loss remains an important negative headline but does not directly explain September 21’s gain.